Results 171 to 180 of about 77,106 (282)

Glycemic therapies and the risk of gastrointestinal adverse events in veterans with type 2 diabetes

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 10, Page 5865-5877, October 2025.
Abstract Aims To compare the risk of gastrointestinal adverse events in new users of glucagon‐like peptide‐1 receptor agonists (GLP‐1RA), sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) and insulin glargine. Materials and Methods We conducted an active comparator, new user design study in veterans with type 2 diabetes who initiated one of these drug
Amara Sarwal   +13 more
wiley   +1 more source

Breaking Free From MCHC Interferences? French‐Speaking Cellular Haematology Group (GFHC) Review of Causes, Rising Trends and Practical Solutions

open access: yesInternational Journal of Laboratory Hematology, Volume 47, Issue 5, Page 798-807, October 2025.
ABSTRACT Mean corpuscular haemoglobin concentration (MCHC) is determined by the ratio of haemoglobin concentration to haematocrit. Managing increased MCHC presents significant challenges, mainly due to variations in analytical methods and pathophysiological conditions.
Sandrine Girard   +7 more
wiley   +1 more source

Target Trial Emulations of GLP‐1 and Dual GLP‐1/GIP Agonists to Reduce Major Adverse Liver Outcomes in Type 2 Diabetes

open access: yesLiver International, Volume 45, Issue 10, October 2025.
ABSTRACT Background Clinical trials suggest GLP‐1 receptor agonists (RAs) and dual glucagon‐like peptide‐1 (GLP‐1)/glucose‐dependent insulinotropic polypeptide (GIP) RAs improve metabolic dysfunction associated with steatohepatitis (MASH) in patients with metabolic dysfunction‐associated steatotic liver disease (MASLD). We aimed to compare the estimate
Alex E. Henney   +5 more
wiley   +1 more source

Are incident gallstones associated to sex‐dependent changes with age? A cohort study

open access: yesAndrology, 2017
D. M. Shabanzadeh   +6 more
semanticscholar   +1 more source

Changing Gastrointestinal Transit Time Alters Microbiome Composition and Bile Acid Metabolism: A Cross‐Over Study in Healthy Volunteers

open access: yesNeurogastroenterology &Motility, Volume 37, Issue 10, October 2025.
Alterations in whole gut transit time (WGTT) significantly impact microbiome composition and bile acid metabolism. Using senna and loperamide, we show that WGTT changes influence bacterial diversity, bile acid profiles, and fibroblast growth factor 19, with effects reversing after 16 days—highlighting the dynamic gut‐microbiome‐bile acid interplay ...
Evette B. M. Hillman   +11 more
wiley   +1 more source

Multiseptate gallbladder with gallstones in a pediatric patient. [PDF]

open access: yesRadiol Case Rep
Yamamichi T   +4 more
europepmc   +1 more source

Gallstones and Risk of Coronary Heart Disease: Prospective Analysis of 270 000 Men and Women From 3 US Cohorts and Meta-Analysis.

open access: yesArteriosclerosis, Thrombosis and Vascular Biology, 2016
Yan Zheng   +10 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy